The company has solid fundamentals for a short-term investment strategy.
Strengths
Historically, the company has been releasing figures that are above expectations.
The stock, which is currently worth 2021 to 0.3 times its sales, is clearly overvalued in comparison with peers.
For the past twelve months, EPS forecast has been revised upwards.
Weaknesses
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company has insufficient levels of profitability.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The company is not the most generous with respect to shareholders' compensation.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past year, analysts have significantly revised downwards their profit estimates.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
